chapter 1 The Landscape of Botanical Medicine Utilization and Safety / chapter 2 Drug Interactions with Botanical Products / chapter 3 In Vitro Inhibition with Botanical Products / chapter 4 Drug Interactions with St. John's Wort and Echinacea / chapter 5 Botanical Products�Drug Interactions: Focus on Garlic, Ginkgo and Ginseng / chapter 6 A Review of Chinese Botanical Product�Drug Interactions / chapter 7 Drug Interactions of Grapefruit and Other Citrus�What Have We Learned? / chapter 8 Quality Assurance and Standardization in Botanical Product�Drug Interaction: Evaluation and Documentation / chapter 9 Pharmacokinetics of Botanical Products / chapter 10 Drug�Drug, Drug�Dietary Supplement, Drug�Citrus Fruit, and Other Food Interactions�Labeling Implications / chapter 11 FDA Perspectives on the Use of Postmarketing Reporting Systems to Evaluate Drug Interactions with CAHP / chapter 12 St. John's Wort Drug Interaction Reports from FDA's Postmarketing AERS / chapter 13 Grapefruit Juice Interaction Reports from FDA's Postmarketing AERS / chapter 14 Botanicals as Drugs: AU.S. Perspective / chapter 15 Development of Botanical Products as Pharmaceutical Agents